Alzheimer Disease
Novel approach may allow women with Alzheimer disease to maintain functional capacity longer
Published in Women's Health Weekly, August 17th, 2006
The company shared its findings from a Phase II clinical trial in women at a symposium held during the 10th International Conference on Alzheimer's Disease and Related Disorders, presented by the Alzheimer's Association. This report expanded on the Phase II data presented in Geneva, Switzerland in April by Dr. Brian Reynolds, director of medical and scientific information for Voyager.
"Women treated with leuprolide acetate and the current standard of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Cancer Prevention
Effect of long-term raloxifene on estradiol may enhance its use as cancer-preventive agent - Cardiovascular Disease
Premenopausal diet is associated with the incidence of postmenopausal heart disease - Colon Cancer
Colon cancer risk in women does not seem to be reduced by physical activity - Geriatrics
Elevated myogenic mRNA levels in older women may reflect attempt to preserve muscle function - Hodgkin Lymphoma
Risk for Hodgkin lymphoma may be modifiable through strenuous physical activity - Adverse Drug Reaction
Mucosal toxicity is an important complication of cancer treatment - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
